BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 Cost of disorders of the brain in Europe 2010
43 auth. A. Gustavsson, Mikael Svensson, F. Jacobi, C. Allgulander, J. Alonso, E. Beghi, R. Dodel, M. Ekman, C. Faravelli, L. Fratiglioni, B. Gannon, David Hilton Jones, P. Jennum, A. Jordanova, L. Jönsson, ... K. Karampampa, M. Knapp, G. Kobelt, T. Kurth, R. Lieb, Mattias Linde, C. Ljungcrantz, A. Maercker, B. Melin, M. Moscarelli, A. Musayev, F. Norwood, M. Preisig, M. Pugliatti, J. Rehm, L. Salvador-Carulla, B. Schlehofer, Roland Simon, H. Steinhausen, L. Stovner, J. Vallat, P. Bergh, J. Os, Pieter H. Vos, Weili Xu, H. Wittchen, B. Jönsson, Jes Olesen
10 2011
10
🐜
🦁 New insights into the burden and costs of multiple sclerosis in Europe
G. Kobelt, A. Thompson, J. Berg, Mia Gannedahl, J. Eriksson
9 2017
9
🦁
🦁 Costs and quality of life of patients with multiple sclerosis in Europe
G. Kobelt, J. Berg, P. Lindgren, S. Fredrikson, B. Jônsson
8 2006
8
🦁
🦁 Costs and quality of life in multiple sclerosis
G. Kobelt, J. Berg, Deborah Atherly, Olympia Hadjimichael
8 2006
8
🦁
🐢 The burden of rheumatoid arthritis and access to treatment: health burden and costs
J. Lundkvist, F. Kastäng, G. Kobelt
7 2007
7
🐢
🦁 TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden
G. Kobelt, K. Eberhardt, P. Geborek
7 2003
7
🦁
🐢 Costs and quality of life of multiple sclerosis in Sweden
J. Berg, P. Lindgren, S. Fredrikson, G. Kobelt
7 2006
7
🐢
🦁 Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of rheumatoid arthritis.
G. Kobelt, L. Jönsson, P. Lindgren, A. Young, K. Eberhardt
7 2002
7
🦁
🐜 Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.
26 auth. P. Rieckmann, D. Centonze, I. Elovaara, G. Giovannoni, E. Havrdová, J. Kesselring, G. Kobelt, D. Langdon, S. Morrow, C. Oreja-Guevara, S. Schippling, C. Thalheim, Heidi Thompson, P. Vermersch, Karen Aston, ... Birgit Bauer, Christine E. Demory, Maria-Paz Giambastiani, J. Hlaváčová, Jocelyne Nouvet-Gire, G. Pepper, Maija Pontaga, Emma Rogan, Chrystal Rogalski, Pieter van Galen, Ali-Frédéric Ben-Amor
6 2018
6
🐜
🦁 The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
G. Kobelt, P. Andlin-Sobocki, S. Brophy, L. Jönsson, A. Calin, Jürgen Braun
6 2004
6
🦁
🐬 The burden of rheumatoid arthritis and access to treatment: uptake of new therapies
B. Jönsson, G. Kobelt, J. Smolen
6 2007
6
🐬